Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.2 (
laccase
)
4,656
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A heterogeneous bead-shaped biocatalyst was prepared by assembling co-immobilization of encapsulating mediator 2,2'-Azino-bis-(3-ethylbenzthiazoline-6-sulphonate) (ABTS) into the functionalized calcium alginate composite beads by grafting glycidyl methacrylate and dopamine and then immobilizing
laccase
covalently onto beads. The enzyme-catalyzed degradation for
acridine
in water was systematically studied for the first time, and it was found that the co-immobilized
laccase
-mediator system has excellent capability to degrade
acridine
in water. Treating 30 mg/L
acridine
aqueous solution for 8 h with the biocatalyst, the degradation rate of
acridine
reached 100 %. In contrast, the degradation of
acridine
by free
laccase
under the same treatment conditions was low and difficult to observe. Its outstanding catalytic activity could be attributed to the effective assembling co-immobilization of
laccase
and the mediator so that the catalytic activity of the enzyme and the synergistic promoting action of the mediator have been given full play in the process of
acridine
degradation. The beaded biocatalyst about 3 mm in diameter could be easily recovered and reused several times without obvious deterioration in catalytic activity. Furthermore, according to the test results of electron paramagnetic resonance and the identified intermediates, the possible biocatalytic mechanism and reaction pathways for
acridine
degradation have been proposed.
...
PMID:Laccase-mediator system assembling co-immobilized onto functionalized calcium alginate beads and its high-efficiency catalytic degradation for acridine. 3292 40